777 related articles for article (PubMed ID: 16598413)
1. Clinical manifestations and antiphosphatidylserine antibodies in patients with systemic lupus erythematosus: is there an association?
Sahin M; Duzgun N; Tunc SE; Tutkak H
Clin Rheumatol; 2007 Feb; 26(2):154-60. PubMed ID: 16598413
[TBL] [Abstract][Full Text] [Related]
2. Isotype distribution and clinical significance of antibodies to cardiolipin, phosphatidic acid, phosphatidylinositol and phosphatidylserine in systemic lupus erythematosus: prospective analysis of a series of 92 patients.
López-Soto A; Cervera R; Font J; Bové A; Reverter JC; Muñoz FJ; Miret C; Espinosa G; Ordinas A; Ingelmo M
Clin Exp Rheumatol; 1997; 15(2):143-9. PubMed ID: 9196865
[TBL] [Abstract][Full Text] [Related]
3. The value of IgA antiphospholipid testing for diagnosis of antiphospholipid (Hughes) syndrome in systemic lupus erythematosus.
Bertolaccini ML; Atsumi T; Escudero Contreras A; Khamashta MA; Hughes GR
J Rheumatol; 2001 Dec; 28(12):2637-43. PubMed ID: 11764209
[TBL] [Abstract][Full Text] [Related]
4. Antibodies to beta2-glycoprotein-I: relation of anticardiolipin antibodies with clinical and laboratory parameters in patients with systemic lupus erythematosus.
Sahin M; Duzgun N; Tunc SE; Tutkak H
Clin Biochem; 2007 May; 40(8):526-30. PubMed ID: 17359958
[TBL] [Abstract][Full Text] [Related]
5. Antibodies to phosphatidylethanolamine in antiphospholipid syndrome and systemic lupus erythematosus: their correlation with anticardiolipin antibodies and beta 2 glycoprotein-I plasma levels.
Vlachoyiannopoulos PG; Beigbeder G; Dueymes M; Youinou P; Hunt JE; Krilis SA; Moutsopoulos HM
Autoimmunity; 1993; 16(4):245-9. PubMed ID: 8025204
[TBL] [Abstract][Full Text] [Related]
6. High frequency of abnormal levels of IgA anti-beta2-glycoprotein I antibodies in patients with systemic lupus erythematosus: relationship with antiphospholipid syndrome.
Fanopoulos D; Teodorescu MR; Varga J; Teodorescu M
J Rheumatol; 1998 Apr; 25(4):675-80. PubMed ID: 9558168
[TBL] [Abstract][Full Text] [Related]
7. Association between systemic non-criteria APS manifestations and antibody type and level: results from the Serbian national cohort study.
Stojanovich L; Kontic M; Djokovic A; Marisavljevic D; Ilijevski N; Stanisavljevic N; Mikovic Z; Petkovic M; Kovcin V
Clin Exp Rheumatol; 2013; 31(2):234-42. PubMed ID: 23306109
[TBL] [Abstract][Full Text] [Related]
8. Immunoglobulin A anti-phospholipid antibodies in Swedish cases of systemic lupus erythematosus: associations with disease phenotypes, vascular events and damage accrual.
Frodlund M; Vikerfors A; Grosso G; Skogh T; Wetterö J; Elvin K; Gunnarsson I; Kastbom A; Dahlström Ö; Rönnelid J; Svenungsson E; Sjöwall C
Clin Exp Immunol; 2018 Oct; 194(1):27-38. PubMed ID: 30208508
[TBL] [Abstract][Full Text] [Related]
9. IgA Antiphospholipid Antibodies in Antiphospholipid Syndrome and Systemic Lupus Erythematosus.
Reshetnyak T; Cheldieva F; Cherkasova M; Lila A; Nasonov E
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012697
[TBL] [Abstract][Full Text] [Related]
10. Anti-beta 2-glycoprotein I and antiphosphatidylserine antibodies are predictors of arterial thrombosis in patients with antiphospholipid syndrome.
Lopez LR; Dier KJ; Lopez D; Merrill JT; Fink CA
Am J Clin Pathol; 2004 Jan; 121(1):142-9. PubMed ID: 14750252
[TBL] [Abstract][Full Text] [Related]
11. Identification of rare anti-phospholipid/protein co-factor autoantibodies in patients with systemic lupus erythematosus.
Szodoray P; Tarr T; Tumpek J; Kappelmayer J; Lakos G; Poor G; Szegedi G; Kiss E
Autoimmunity; 2009 Sep; 42(6):497-506. PubMed ID: 19626489
[TBL] [Abstract][Full Text] [Related]
12. Thrombotic risk assessment in antiphospholipid syndrome: do noncriteria antibodies contribute?
Uludağ Ö; Çinar S; McDonnell T; Çene E; Yalçinkaya Y; Gül A; Inanç M; Artim Esen B
Turk J Med Sci; 2023; 53(5):1067-1074. PubMed ID: 38813003
[TBL] [Abstract][Full Text] [Related]
13. Antibodies to anionic phospholipids and anti-beta2-GPI: association with thrombosis and thrombocytopenia in systemic lupus erythematosus.
Amoroso A; Mitterhofer AP; Del Porto F; Garzia P; Ferri GM; Galluzzo S; Vadacca M; Caccavo D; Afeltra A
Hum Immunol; 2003 Feb; 64(2):265-73. PubMed ID: 12559629
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of IgA anticardiolipin and anti-beta2-GP1 antibodies in patients with systemic lupus erythematosus and primary antiphospholipid syndrome.
Samarkos M; Davies KA; Gordon C; Loizou S
Clin Rheumatol; 2006 Mar; 25(2):199-204. PubMed ID: 16091839
[TBL] [Abstract][Full Text] [Related]
15. Prevalence of antibodies to beta2-glycoprotein I in systemic lupus erythematosus and their association with antiphospholipid antibody syndrome criteria: a single center study and literature review.
Bruce IN; Clark-Soloninka CA; Spitzer KA; Gladman DD; Urowitz MB; Laskin CA
J Rheumatol; 2000 Dec; 27(12):2833-7. PubMed ID: 11128672
[TBL] [Abstract][Full Text] [Related]
16. Clinical significance of antiphospholipid protein antibodies. Receiver operating characteristics plot analysis.
Musial J; Swadzba J; Motyl A; Iwaniec T
J Rheumatol; 2003 Apr; 30(4):723-30. PubMed ID: 12672190
[TBL] [Abstract][Full Text] [Related]
17. Longitudinal study of antinuclear and anticardiolipin antibodies in pregnant women with systemic lupus erythematosus and antiphospholipid syndrome.
Salazar-Páramo M; Jara LJ; Ramos A; Barile L; Machado G; García-De La Torre I
Rheumatol Int; 2002 Aug; 22(4):142-7. PubMed ID: 12172952
[TBL] [Abstract][Full Text] [Related]
18. Significance of antiprothrombin antibodies in patients with systemic lupus erythematosus: clinical evaluation of the antiprothrombin assay and the antiphosphatidylserine/prothrombin assay, and comparison with other antiphospholipid antibody assays.
Tsutsumi A; Hayashi T; Chino Y; Mamura M; Goto D; Matsumoto I; Ito S; Sumida T
Mod Rheumatol; 2006; 16(3):158-64. PubMed ID: 16767554
[TBL] [Abstract][Full Text] [Related]
19. Added value of non-criteria antiphospholipid antibodies for antiphospholipid syndrome: lessons learned from year-long routine measurements.
Žigon P; Podovšovnik A; Ambrožič A; Tomšič M; Hočevar A; Gašperšič N; Rotar Ž; Praprotnik S; Šemrl SS; Čučnik S
Clin Rheumatol; 2019 Feb; 38(2):371-378. PubMed ID: 30099654
[TBL] [Abstract][Full Text] [Related]
20. Relationship between antiphosphatidylserine/prothrombin and conventional antiphospholipid antibodies in primary antiphospholipid syndrome.
Hoxha A; Ruffatti A; Mattia E; Meneghel L; Tonello M; Salvan E; Pengo V; Punzi L
Clin Chem Lab Med; 2015 Jul; 53(8):1265-70. PubMed ID: 25562605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
